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Abstract
Background: Strategies to improve medication adherence are widespread in the literature; however, their impact is limited in
real practice. Few patients persistently engage long-term to improve health outcomes, even when they are aware of the consequences
of poor adherence. Despite the potential of mobile phone apps as a tool to manage medication adherence, there is still limited
evidence of the impact of these innovative interventions. Real-world evidence can assist in minimizing this evidence gap.
Objective: The objective of this study was to analyze the impact over time of a previously implemented digital therapeutic
mobile app on medication adherence rates in adults with any chronic condition.
Methods: A retrospective observational study was performed to assess the adherence rates of patients with any chronic condition
using Perx Health, a digital therapeutic that uses multiple components within a mobile health app to improve medication adherence.
These components include gamification, dosage reminders, incentives, educational components, and social community components.
Adherence was measured through mobile direct observation of therapy (MDOT) over 3-month and 6-month time periods.
Implementation adherence, defined as the percentage of doses in which the correct dose of a medication was taken, was assessed
across the study periods, in addition to timing adherence or percentage of doses taken at the appropriate time (±1 hour). The
Friedman test was used to compare differences in adherence rates over time.
Results: We analyzed 243 and 130 patients who used the app for 3 months and 6 months, respectively. The average age of the
243 patients was 43.8 years (SD 15.5), and 156 (64.2%) were female. The most common medications prescribed were varenicline,
rosuvastatin, and cholecalciferol. The median implementation adherence was 96.6% (IQR 82.1%-100%) over 3 months and
96.8% (IQR 87.1%-100%) over 6 months. Nonsignificant differences in adherence rates over time were observed in the 6-month
analysis (Fr(2)=4.314, P=.505) and 3-month analysis (Fr(2)=0.635, P=.728). Similarly, the timing adherence analysis revealed
stable trends with no significant changes over time.
Conclusions: Retrospective analysis of users of a medication adherence management mobile app revealed a positive trend in
maintaining optimal medication adherence over time. Mobile technology utilizing gamification, dosage reminders, incentives,
education, and social community interventions appears to be a promising strategy to manage medication adherence in real practice.
(J Med Internet Res 2020;22(8):e17834) doi: 10.2196/17834
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Strategies to manage medication adherence, which is defined
as the process by which patients take their medications as
prescribed [1], are widespread in the literature and are reported
to be modestly effective [2]. Most likely due to the
multidimensional nature of medication-taking behavior and
numerous determinants of nonadherence [3], multicomponent
interventions with both technical and educational aspects have
shown the most success [4]. However, these strategies have
failed to find success in the real world; patient adherence levels
tend to decrease in the long term and stay consistently at around
50% [5]. These strategies are limited not only by the capacity
of the health care system delivering them but also by low levels
of patient engagement. Even when patients are aware of the
risks and consequences of diseases, few engage persistently in
therapies to improve health outcomes [6-8].
Cognitive biases resulting in irrational and unhealthy behavior
may be a key contributor to patient engagement in preventative
health strategies. In contrast with traditional economic models
of rational choice, modern insights have suggested that human
behavior is highly influenced by the context or environment of
our decision-making process rather than by price signals or
factual information [9]. The field of behavioral economics
combines psychology and neoclassical economics to shed light
on the errors in mental processing that prevent patients from
making rational and beneficial decisions to improve their health
[10]. Some health behaviors may require high levels of
self-control, meaning that a patient may need to endure “certain
and immediate inconveniences in return for uncertain and distant
benefits [11].” Obvious behaviors that create this paradigm are
healthy food choices and exercise [12]. However, medication
adherence, or the act of taking a medication at a certain time
each day, creates inconvenience by disrupting the patient’s daily
lifestyle or causing adverse effects; meanwhile, this behavior
is only rewarded with uncertain and distant future health
outcomes.
Strategies to influence cognitive biases include incentives and
rewards. Incentives and rewards not only impact motivation but
also create an immediate benefit to counteract inconvenience
[13]. In previous literature, financial incentives showed success
in improving medication adherence but were limited by
long-term viability and capacity of resources, with economic
incentives often eroding the potential economic gain [13-19].
The use of lottery-based incentives has also shown success in
sustainment of adherence and long-term engagement [20,21].
Frequent lotteries with small rewards can engage patients based
on regret aversion, namely the understanding that the emotional
cost of regret (ie, missing a reward by not taking a medication
dose) is significant [21].
Methods of gamification or use of nonfinancial extrinsic
motivators, such as accruing “points,” can be feasible and
practical ways to create similar senses of gratification and
motivation [22]. Gamification is the application of game
elements for purposes other than their expected use for
entertainment [23]. An individual’s choice to engage in an
activity is affected by extrinsic and intrinsic motivation.
Medication adherence requires intrinsic motivation driven by
internal rewards; this sense of motivation can often be difficult
to achieve for behavior that has uncertain and distant health
benefits. Through the use of gamification, extrinsic motivators
such as earning points and monetary rewards can create and
trigger internal motivation [23]. Gamification is not only able
to use both extrinsic and intrinsic motivation to create consistent
engagement through rewards, such as points or daily streaks,
but can also create a sense of achievement [23]. Both
gamification and rewards appear to be promising strategies to
potentiate the effects of frequently used adherence management
approaches, such as educational components and reminders.
Currently, over 300,000 mobile health (mHealth) apps are
available; they have become common and instrumental tools
for health behavior change in modern times [24,25]. Success
has already been demonstrated with using mobile phone apps
to support health behavior changes, ranging from constructing
a healthy diet to managing chronic pain or improving physical
activity [26-28]. Despite the potential of mobile phone apps as
a tool to manage medication adherence, there is limited evidence
of the effectiveness of these innovative interventions [29-31].
Real-world evidence, which refers to health care information
gathered outside clinical research settings, can help minimize
this evidence gap. Generated through the analysis of multiple
sources, including electronic health records and mHealth apps,
real-world evidence can be used to test how health interventions
work in usual practice [32]. Observational studies of real-world
data can assist in evaluating the potential impact of implemented
health interventions in real world settings, such as interventions
delivered through mobile phone apps [33].
The objective of this study was to use real-world data to analyze
the impact over time of a previously implemented digital
therapeutic mobile app on medication adherence rates in adults
with any chronic condition. The impact on timing adherence
rates was also analyzed.
Methods
Study Design
This was a retrospective observational study using real-world
data. The implementation adherence of people in Australia using
a commercially available smartphone application, Perx, was
evaluated. The ESPACOMP Medication Adherence Reporting
Guideline (EMERGE) and STrengthening the Reporting of
OBservational Studies in Epidemiology (STROBE) Statement
were used [1,34].
Intervention: Perx Digital Therapeutic
Perx is a digital therapeutic that uses different components
within a mobile app to improve adherence to medications. These
include technical components (through dosage reminders based
on the individual patient’s dosing regimen and individualized
visual adherence feedback), educational components (through
the use of educational materials on the disease and medications
used), incentives and rewards (lottery-style delivery of gift
cards), a social community (through a chat forum and
collaborative competition dynamics), and gamification (through
the use of point-earning and minigames to enhance the
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medication-taking experience). Perx enables users to input their
medication schedule information while sending dosage
reminders based on the individual patient’s regimen. Doses
taken are self-reported and recorded by mobile direct
observation of therapy (MDOT) photo verification [35]. “Gold”
points are rewarded to users for each dose taken on time (±1
hour). Additionally, different minigames are offered at the time
of a medication dose to enhance the medication-taking
experience. The patient can earn extra gold points through
learning a daily fact about their medication or disease state and
by completing all daily tasks. Supplementary tasks within the
app include health measurements, appointment reminders,
physical therapy sessions, and other health actions, which
provide users with a comprehensive system to track their health
in addition to visual adherence feedback on their personal
progress. A social forum and leaderboard component are also
included, which create a Perx community. Reward shopping
vouchers for popular stores can be redeemed either with a certain
amount of gold earned or randomly by taking a correct dose.
Screenshots showing the different features of the app can be
found in Multimedia Appendix 1.
Data Source and Patients
Deidentified user data from the Perx database were analyzed
for this study to assess adherence dosing data between October
2018 and May 2019 within Australia. All information was
deidentified, including medications, doses, schedules, user age,
dosages taken and missed, and timestamps of dosages taken.
Users were recruited to use the app via a range of channels,
including patient advocacy organizations (ie, Cystic Fibrosis
Australia and Diabetes NSW & ACT), local community
pharmacies, outpatient clinics at local hospitals, and app stores.
App users with any chronic condition were included in the
analysis. Two user cohorts were analyzed: one for users who
used the app consistently for over 6 months and one for users
who used the app consistently for 3 months. Users were
excluded from the analysis if they used the intervention for less
than 30% of the time period defined by the number of days
active on the app. The 30% threshold was used because it
excluded patients who appeared to decide to stop using the app
during the time period of the analysis, as the objective was to
analyze user medication adherence rather than adherence to the
app itself.
A subanalysis of timing adherence was also performed for both
time periods. Users were excluded from the subanalysis if
timestamps were not available for the entire time period.
Outcome: Medication Adherence
Adherence implementation rates (where adherence
implementation was defined as the extent to which a patient’s
actual dosing corresponded to the prescribed dosing regimen
[1]) were calculated by dividing doses taken by total doses
scheduled per 30-day period. This included doses taken outside
the ±1-hour time period and was verified by comparing the
recorded timestamps to the dosing schedules inputted within
the app.
For the subanalysis, timing adherence was assessed with doses
taken at the correct time (±1 hour) over total doses scheduled
per 30-day period. This additional analysis was performed to
understand the effects of the incentives, as users could only
redeem incentives if the medication was taken within the ±1
hour time threshold. Both adherence measures are presented as
percentages. Rates were compared to an optimal adherence level
of 80%, which is the most commonly used cutoff point in the
literature [36,37].
Data Analysis
Data were analyzed by integrating the PROC SQL (SAS
University Edition 9.4) and Python (Jupyter Lab 1.0) language
programs and Microsoft Excel 2019 (Microsoft Corporation)
to organize and retrieve the results. The analysis was conducted
in 30-day time periods. Study variables were summarized using
mean (SD) and median (IQR). Adherence variables were verified
for normal distribution using the Shapiro-Wilk test. Due to the
distribution of the data, the Friedman test was used to compare
differences in adherence rates over time. A P value <.05 was
considered to indicate statistical significance.
Ethics Statement
The University of Technology Sydney Human Research Ethics
Committee (HREC) approved this study (ETH19-3622). All
users recruited into the program were required to actively accept
and consent to the Terms of Use and Privacy Policy, which
stated that de-identified data in aggregated form may be used
by third parties for research and other purposes. No personal or
confidential data were included in the database; therefore,
informed patient consent was not required.
Results
Study Sample
A total of 130 users were included in the 6-month analysis, and
243 users were included in the 3-month analysis. For the timing
adherence subanalysis, 111 users and 221 users were included
in the 6-month and 3-month analyses, respectively.
6-Month Analysis Group
The distribution of users according to gender was 36/130 male
(27.7%) and 88/130 (67.7%); 6/130 users (4.6%) did not disclose
their gender. The average age was 45.8 years (SD 17.2). The
most common medications prescribed were rosuvastatin,
cholecalciferol, and atorvastatin; the mean number of
medications prescribed per patient was 4.3 (SD 3.1).
3-Month Analysis Group
The distribution of users according to gender was 80/243 male
(32.9%) and 156/243 female (64.2%); 7/243 users (2.9%) did
not disclose their gender). The average age was 43.8 years (SD
15.5). The most common medications prescribed were
varenicline, rosuvastatin, and cholecalciferol; the mean number
of medications prescribed per patient was 4.0 (SD 2.9).
Implementation Adherence
Adherence rates across the 6-month time period are shown in
Table 1. The overall median implementation adherence was
96.8% (IQR 87.1%-100%) across 6 months. A small decreasing
trend was observed from month 4 to month 6. However, the
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Friedman test revealed non-significant differences in adherence
rates over time (Fr(2)=4.314, P=.505) (Figure 1).
Adherence rates across the 3-month time period are shown in
Table 1. The overall median implementation adherence was
96.6% (IQR 82.1%-100%) across 3 months. A slight decreasing
trend was seen from month 1 to month 3 (Figure 2). Similarly
to the 6-month analysis, nonsignificant differences in adherence
rates over time were found (Fr(2)=0.635, P=.728).
Table 1. Adherence rates across the 6-month and 3-month time periods.
Median (IQR)Mean (SD)Study period
6-month analysis (%)
96.8 (88.0-100)88.6 (21.5)Month 1
96.8 (82.5-100)88.0 (20.3)Month 2
97.1 (87.1-100)89.5 (18.5)Month 3
98.3 (86.5-100)88.6 (20.9)Month 4
97.1 (85.7-100)87.0 (24.0)Month 5
96.8 (83.9-100)83.9 (26.9)Month 6
96.8 (87.1-100)87.6 (16.9)Overall
3-month analysis (%)
96.1 (86.1-99.6)87.3 (21.1)Month 1
96.8 (79.0-100)84.1 (24.7)Month 2
96.7 (80.6-100)82.5 (27.5)Month 3
96.6 (82.1-100)84.6 (20.9)Overall
Figure 1. Mean implementation adherence rates of 130 users of the Perx app over 6 months. The shaded area below 80% indicates less than optimal
adherence based on the literature.
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Figure 2. Mean implementation adherence rates of 243 users of the Perx app over 3 months. The shaded area below 80% indicates less than optimal
adherence based on the literature.
Timing Adherence Subanalysis
Timing adherence rates across study time periods can be found
in Table 2. For the 111 users included in the 6-month timing
adherence analysis, their adherence remained unchanged, with
medians of 77.3% (IQR 52.0%-93.1%) in month 1 and 77.4%
(IQR 36.2%-94.4%) in month 6. The median value across the
time periods was 79.0% (IQR 50.8%-92.9%). Overall, there
were no significant changes over time (Fr(2)=5.465, P=.362)
(Figure 3).
In the 3-month timing adherence analysis, 221 users’adherence
remained stable (Table 2), with nonsignificant changes across
time periods (Fr(2)=2.125, P=.346) (Figure 4).
Table 2. Timing adherence across the 6-month and 3-month time periods.
Median (IQR)Mean (SD)Study period
6-month analysis (%)
77.3 (52.0-93.1)68.4 (27.9)Month 1
82.3 (54.8-91.9)70.5 (28.4)Month 2
79.8 (50.3-93.5)69.2 (27.7)Month 3
81.7 (51.4-93.5)69.8 (28.8)Month 4
80.6 (52.8-92.7)68.7 (28.9)Month 5
77.4 (36.2-94.4)63.4 (33.7)Month 6
79.0 (50.8-92.9)68.5 (29.1)Overall
3-month analysis (%)
71.0 (46.4-85.9)63.7 (28.2)Month 1
74.2 (41.9-90.3)64.0 (30.8)Month 2
71.0 (34.7-88.7)61.4 (32.3)Month 3
72.0 (41.8-88.3)61.1 (28.5)Overall
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Figure 3. Mean timing adherence rates of 111 users of the Perx app over 6 months. The users were considered to be adherent to the dose if it was taken
within ±1 hour of the scheduled time.
Figure 4. Mean timing adherence rates of 221 users of the Perx app over 3 months. The users were considered to be adherent to the dose if it was taken
within ±1 hour of the scheduled time.
Discussion
Principal Findings
Retrospective analysis of the medication adherence of users
receiving a multicomponent adherence management intervention
that includes reminders, educational components, incentives,
gamification, and social community components demonstrated
that this intervention is a successful approach to maintaining
optimal medication adherence. To our knowledge, this is the
first study investigating a comprehensive multicomponent
mobile intervention to maintain medication adherence across
different chronic conditions.
Trends observed from the users of the mobile app showed high
rates of adherence across the study periods. The adherence rates
of Perx users averaged over 85% across six months. This was
significantly higher than previously observed dispensing data
adherence rates in Australian patients, which were found to be
between 50.2% and 66.9% [38]. While a slight decrease in
adherence was observed over 6 months, the long-term rates
remained above 80%, which is often considered to be an optimal
threshold for medication adherence [36]. The decrease in
adherence rates was found to be statistically insignificant
[36][39]. The gradual decrease was less pronounced than that
in previous literature examining the long-term effects and
multidimensional, dynamic nature of medication adherence; in
a previous study, average adherence was estimated to decrease
by 1.1% per month [40]. This suggests that the addition of
gamification and incentive components to more traditional
management interventions (eg, educational components and
reminders) is a viable option to inspire long-term motivation
and adherence to medications.
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A recent network meta-analysis examined the impact of
adherence interventions across time and identified
multicomponent interventions as the most effective long-term
solution [4]. Although there is limited evidence, interventions
that include incentives and technical aspects (ie, dosage
reminders) have been shown to be the most effective in
sustaining long-term results [4]. The Perx digital therapeutic
presents an advantageous alternative to existing medication
adherence interventions due to its incorporation of multiple and
innovative components into one platform to continuously
motivate and empower users. A main component of the Perx
app, medication reminders, has long been identified as a
successful intervention component to improve adherence
[41,42]. However, although medication reminders help to
enhance adherence, they only affect one dimension of the
multiple nonadherence determinants and are frequently used in
combination with additional interventions, such as education
[4]. Educational interventions are also a common long-term
strategy to improve adherence to medications [2,43]. Delivered
by numerous methods, these interventions can be moderately
effective; however, they are not a sole solution to improve
adherence for all patients [44]. When combined with technical
and attitudinal components such as motivational interviewing,
education-based strategies are found to be even more successful
[4].
Motivation is another common determinant of medication
adherence [3]. Patients can be fully aware of the positive health
benefits medications provide as well as the consequences of
poor health behavior; however, some patients consistently make
poor health choices [11]. Present-biased preferences explain
the “human tendency to grab immediate rewards and to avoid
immediate costs in a way that our ‘long-run selves’ do not
appreciate [10].” An individual may analyze immediate costs
or immediate rewards to make a decision; such decisions often
result from impatience or immediate gratification and place
greater value on achieving gratification in the present moment
than obtaining the same reward in the future. Positive and
negative health outcomes remain too distant of a reward and
consequence, respectively [45]. The Perx digital therapeutic
aims to create instant gratification through gamification
elements. Through receiving instant praise and reward after
each medication dose taken on time, users may be motivated
to continue to be adherent. Motivation can additionally be
created through intrinsic forces, as stated by the
self-determination theory. The self-determination theory
suggests that the nature of perceptible motivational types
determines the predictability and force of how people behave,
rather than the amount of motivation [46,47]. Therefore, it is
necessary for gamified systems to promote a sense of autonomy,
competence, and relatedness to create the intrinsic motivation
needed to continue the value of the extrinsic motivating factors
[46,48]. The Perx digital therapeutic intervention may be
successful because it meets the users’ need for competence,
autonomy, and relatedness. Competence and autonomy are
created by setting challenging yet manageable goals, where
adherence is the challenge and financial incentives are the goals.
Users can also follow their progress through points,
leaderboards, and personal visualized feedback graphs on their
individual adherence. This feedback provides additional positive
reinforcement and has been proven to be a successful component
of interventions to improve medication adherence; it is estimated
that adherence increases 8.8% for interventions where feedback
is included compared to those that do not include feedback
[40,49]. The social community component meets the need for
relatedness by fostering a feeling of belonging to a community
that shares the common goal of better health [46].
While gamification is a main force in creating motivation in the
app, the impact of rewards and incentives cannot be dismissed.
The use of incentives in public policy has long been used as an
extrinsic force to influence behavior and intrinsic motivation
[9,50,51]. However, the use of incentives to encourage health
behaviors is relatively new, and more research is needed in this
area. Financial incentives have proven to improve medication
adherence in certain populations; however, their long-term
viability can be questioned due to the resources needed [13-19].
Although incentives can be critiqued on their superficial nature
or short-term viability, they may be a powerful motivating factor
in creating habit-based behavior, a proven successful key in
improving medication adherence, and an intrinsic source of
motivation [51,52]. In the case of Perx, the extrinsic nature of
the incentives may create habit-based adherence behavior in
addition to intrinsic motivation to improve health outcomes.
Additionally, the Perx app uses lottery-based incentives rather
than predictable rewards. These incentives can enhance health
behavior based on regret aversion or the human tendency to
place a significant cost on regret [20]. If users believe that
missing a medication dose can prevent them from winning a
reward, they are still likely to improve their adherence, even
without a guaranteed instant reward [21].
Limitations
Although our analysis proved that the Perx digital therapeutic
is an effective intervention in managing medication adherence,
it does have some limitations. First, the number of app users
with available data was limited, did not extend past 6 months
for the majority of users, and did not include information on
the users’ clinical conditions. Due to this, we were unable to
perform subanalyses based on patient age, gender, medication,
or condition. Second, we could not establish baseline adherence
rates before the intervention was implemented or evaluate a
control group due to the retrospective nature of the study. Third,
while we believe that our sample reflects an accurate sample of
patients who would be likely to use a mobile app to manage
medications, the users who downloaded the app may also have
been likely to adhere to their medications without the app.
Conversely, it could also be argued that patients who need
adherence management support would be more likely to
download the app. Finally, while we could measure the number
of active days per patient, it was not possible to determine full
user engagement of the intervention in this analysis to
understand the extent to which the intervention was used by
each user.
Strengths
One strength of our study is our measure of adherence,
self-reporting with MDOT [35]. Similar to electronic methods
such as the Medication Event Monitoring System (MEMS),
MDOT enables objective measurement while simultaneously
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providing timestamps to additionally measure timing adherence,
which is an important component of the multidimensional
medication-taking process [35]. Additionally, our analysis of
the gamification of mobile apps to maintain positive health
behaviors is part of a new and emerging research landscape
within the pharmacy and health care sector that has not been
previously examined [53]. With the increasing number of health
apps entering the market, supportive evidence is necessary to
demonstrate the effectiveness of these tools and to indicate
whether they should be recommended by health care
professionals as a component of medication therapy [54,55].
Finally, our use of real-world data generated from users of this
commercially available mobile app was a strength in that the
data can be applied to a broader population of patients and
reflect actual use in practice [32].
Future Work
A 12-month clinical trial is currently being conducted with the
objective of assessing the efficacy of the Perx intervention in
adherence and clinical outcomes. Future research should aim
to assess the effectiveness of this intervention in improving
adherence to medications and other gamification- or
incentive-based strategies in addition to observing the impact
on clinical health outcomes. Furthermore, a longer analysis
period of 12 to 24 months would be beneficial in observing the
long-term effects to determine if these types of interventions
can sustain gold-standard adherence rates above 80% for longer
than 6 months. It would additionally be useful to analyze the
impact of the intervention across different points in the
medication-taking process, such as initiation of medication,
implementation and persistence adherence, and time to
discontinuation of medication [1]. Finally, the opinions of
stakeholders, specifically users, regarding the app and
intervention components are vital to understand the main
motivating factor in promoting adherence. A full engagement
analysis identifying the components of the app on which the
most time is spent as well as a user survey analysis are required
to obtain a complete understanding of the success of the
intervention.
Conclusion
Retrospective analysis of a digital therapeutic mobile app that
merges gamification, education, reminders, a social community,
and incentive-based components indicates that this intervention
is successful in maintaining optimal medication adherence over
time. Extrinsic external monetary motivators combined with
fundamental game mechanics and other common behavioral
change components may be a key force to promote intrinsic
motivation and habit-based behavior, which can spark long-term
changes in health behavior. Future research should evaluate the
long-term impact of mobile apps using these components over
a longer time period using experimental designs.
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